Literature DB >> 18812897

Increased intracapsular pressures after unstable slipped capital femoral epiphysis.

Jose A Herrera-Soto1, Michael F Duffy, Mark A Birnbaum, Kelly L Vander Have.   

Abstract

BACKGROUND: Osteonecrosis of the femoral head is the most dreaded complication associated with an unstable slipped capital femoral epiphysis (SCFE). We hypothesize that the hip joint pressure will be increased in unstable slips, confirming that emergent treatment and decompression are warranted.
METHODS: Thirteen unstable SCFE hips were evaluated. Hip pressure monitoring was performed. Postcapsulotomy measurements were also performed in all of the patients. Five of these under gentle manipulation. Six patients underwent measurement of the hip pressure on the unaffected side.
RESULTS: The mean pressure on the affected hip was 48 mm Hg. The mean pressure on the unaffected side was 23 mm Hg. There was a significant increase in intraarticular hip pressure after attempted manipulation (mean, 75 mm Hg). DISCUSSION: Hip pressures are increased in unstable SCFE to levels higher for those of a compartment syndrome probably causing a tamponade effect. There is a need to perform a capsulotomy if manipulation is performed.

Entities:  

Mesh:

Year:  2008        PMID: 18812897     DOI: 10.1097/BPO.0b013e318186bda3

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  11 in total

1.  Open reduction and internal fixation of unstable slipped capital femoral epiphysis by means of surgical dislocation does not decrease the rate of avascular necrosis: a preliminary study.

Authors:  Cristina Alves; Marie Steele; Unni Narayanan; Andrew Howard; Benjamin Alman; James G Wright
Journal:  J Child Orthop       Date:  2012-07-20       Impact factor: 1.548

2.  Closed bone graft epiphysiodesis for avascular necrosis of the capital femoral epiphysis.

Authors:  George H Thompson; Ethan S Lea; Kenneth Chin; Raymond W Liu; Jochen P Son-Hing; Allison Gilmore
Journal:  Clin Orthop Relat Res       Date:  2013-07       Impact factor: 4.176

3.  Is Assessment of Femoral Head Perfusion During Modified Dunn for Unstable Slipped Capital Femoral Epiphysis an Accurate Indicator of Osteonecrosis?

Authors:  Eduardo N Novais; Ernest L Sink; Lauryn A Kestel; Patrick M Carry; João C M Abdo; Travis C Heare
Journal:  Clin Orthop Relat Res       Date:  2016-04-18       Impact factor: 4.176

4.  Intraoperative Monitoring of Epiphyseal Perfusion in Slipped Capital Femoral Epiphysis: Surgical Technique.

Authors:  Tim Schrader; K Aaron Shaw
Journal:  JBJS Essent Surg Tech       Date:  2017-01-11

5.  Slipped upper femoral epiphysis: Outcome after in situ fixation and capital realignment technique.

Authors:  Sanjay Arora; Vivek Dutt; Thomas Palocaren; Vrisha Madhuri
Journal:  Indian J Orthop       Date:  2013-05       Impact factor: 1.251

6.  Hip decompression of unstable slipped capital femoral epiphysis: a systematic review and meta-analysis.

Authors:  Talal Ibrahim; Shady Mahmoud; Muhammad Riaz; Abdelsalam Hegazy; David G Little
Journal:  J Child Orthop       Date:  2015-03-17       Impact factor: 1.548

7.  Slipped capital femoral epiphysis: a spectrum of surgical care and changes over time.

Authors:  R T Loder
Journal:  J Child Orthop       Date:  2017-04       Impact factor: 1.548

8.  Slipped capital femoral epiphysis: a population-based study.

Authors:  Bengt Herngren; Margaretha Stenmarker; Ludek Vavruch; Gunnar Hagglund
Journal:  BMC Musculoskelet Disord       Date:  2017-07-18       Impact factor: 2.362

9.  Outcomes after slipped capital femoral epiphysis: a population-based study with three-year follow-up.

Authors:  B Herngren; M Stenmarker; K Enskär; G Hägglund
Journal:  J Child Orthop       Date:  2018-10-01       Impact factor: 1.548

Review 10.  Factors Affecting Outcomes of Slipped Capital Femoral Epiphysis.

Authors:  Panagiotis V Samelis; Eftychios Papagrigorakis; Apostolos-Lykourgos Konstantinou; Harris Lalos; Panagiotis Koulouvaris
Journal:  Cureus       Date:  2020-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.